XML 84 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1

Stock Based Compensation (Tables)

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

Stock Options Activity

Stock option activity for the years ended December 31, 2021, 2020 and 2019 is summarized as follows:

			Number of Shares						Weighted-Average Exercise Price						Weighted-Average Remaining Contractual Life (In Years)						Aggregate Intrinsic Value
Options outstanding at January 1, 2019			707,777						$	56.84
Granted			—						—
Exercised			(189,436)						32.39
Canceled			—						—
Options outstanding at December 31, 2019			518,341						$	65.77
Granted			—						—
Exercised			(42,740)						23.11
Canceled			—						—
Options outstanding at December 31, 2020			475,601						$	69.61
Granted			—						—
Exercised			(70,776)						41.63
Canceled			—						—
Adjustment due to Consensus Separation (1)			35,749						$	68.25
Options outstanding at December 31, 2021			440,574						$	68.45					5.93						$18,683,104
Exercisable at December 31, 2021			168,614						$	67.62					5.81						$7,290,699
Vested and expected to vest at December 31, 2021			440,574						$	68.45					5.93						$18,683,104

(1) As noted above, in connection with the Consensus separation and pursuant to the anti-dilution provisions of the 2007 Plan and the 2015 Plan, the number of shares underlying each stock option outstanding as of the date of the Separation was multiplied by a factor of approximately 1.09 and the related exercise price for the stock options was divided by a factor of approximately 1.09, which was intended to preserve the intrinsic value of the awards prior to the Separation.

Summarized Information Concerning Outstanding and Exercisable Options

The following table summarizes information concerning outstanding and exercisable options as of December 31, 2021:

						Options Outstanding																		Exercisable Options
Range of Exercise Prices						Number Outstanding December 31, 2021						Weighted Average Remaining Contractual Life						Weighted Average Exercise Price						Number Exercisable December 31, 2021						Weighted Average Exercise Price
$27.15						5,439						0.17 years						$	27.15					5,439						$	27.15
68.97						435,135						6.00 years						68.97						163,175						68.97
$27.15 - $68.97						440,574						5.93 years						$	68.45					168,614						$	67.62

Valuation Assumptions of Market-based Restricted Stock Awards Granted

The weighted-average fair values of market-based restricted stock awards granted have been estimated utilizing the following assumptions:

			December 31, 2021						December 31, 2020						December 31, 2019
Underlying stock price at valuation date			$	113.27					$	91.17					$	84.58
Expected volatility			30.3		%				27.0		%				28.3		%
Risk-free interest rate			1.3		%				0.7		%				2.5		%

Restricted Stock and Restricted Stock Unit Award Activity

Restricted stock award activity for the years ended December 31, 2021, 2020 and 2019 is set forth below:

			Shares						Weighted-Average Grant-Date Fair Value
Nonvested at January 1, 2019			1,207,011						$	64.82
Granted			187,773						79.00
Vested			(172,884)						73.65
Canceled			(116,841)						72.58
Nonvested at December 31, 2019			1,105,059						$	64.76
Granted			1,268						98.63
Vested			(264,172)						70.25
Canceled			(21,589)						79.34
Nonvested at December 31, 2020			820,566						$	62.66
Granted			—						—
Vested			(435,529)						60.52
Canceled			(33,194)						83.23
Adjustment due to Consensus Separation (1)			32,120						74.62
Nonvested at December 31, 2021			383,963						$	41.45

(1) As noted above, in connection with the Consensus separation and pursuant to the anti-dilution provisions of the 2007 Plan and the 2015 Plan, the number of shares underlying each restricted stock award outstanding as of the date of the Separation was multiplied by a factor of approximately 1.09 and the market condition stock price target for marked-based restricted stock awards was also adjusted.

Restricted stock unit activity for the years ended December 31, 2021, 2020 and 2019 is set forth below:

			Number of Shares						Weighted-Average Remaining Contractual Life (in Years)						Aggregate Intrinsic Value
Outstanding at January 1, 2019			41,231
Granted			3,844
Vested			(12,343)
Canceled			(11,858)
Outstanding at December 31, 2019			20,874
Granted			210,630
Vested			(9,029)
Canceled			(12,691)
Outstanding at December 31, 2020			209,784
Granted			319,345
Vested			(124,761)
Canceled			(60,201)
Adjustment due to Consensus Separation (1)			16,576
Outstanding at December 31, 2021			360,743						2.71						$	39,991,969
Vested and expected to vest at December 31, 2021			360,743						2.71						$	39,991,969

(1) As noted above, in connection with the Consensus separation and pursuant to the anti-dilution provisions of the 2007 Plan and the 2015 Plan, the number of shares underlying each restricted stock unit outstanding as of the date of the Separation was multiplied by a factor of approximately 1.09 and the market condition stock price target for marked-based restricted stock units was also adjusted.

Valuation Assumptions of Stock Options Granted

The compensation expense related to the Purchase Plan has been estimated utilizing the following assumptions:

						December 31, 2021						December 31, 2020						December 31, 2019
Risk-free interest rate						0.05%						0.73%						2.31%
Expected term (in years)						0.5						0.5						0.5
Dividend yield						0.00%						0.00%						1.02%
Expected volatility						35.00%						25.33%						24.63%
Weighted average volatility						35.00%						25.33%						24.63%

X

- Definition

[Table Text Block] for Schedule of Share-based Payment Award, Performance Awards, Valuation Assumptions [Table Text Block] [Table]

+ References

No definition available.

+ Details

Name:	jcom_ScheduleofSharebasedPaymentAwardPerformanceAwardsValuationAssumptionsTableTextBlockTableTextBlock
Namespace Prefix:	jcom_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration